THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 125 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,215,000 | -94.0% | 119,854 | -94.7% | 0.02% | -94.6% |
| Q2 2022 | $20,326,000 | +60.3% | 2,243,473 | +69.1% | 0.31% | +51.9% |
| Q1 2022 | $12,683,000 | +99.6% | 1,326,653 | +130.7% | 0.21% | +126.4% |
| Q4 2021 | $6,355,000 | -56.6% | 575,113 | -70.9% | 0.09% | -61.9% |
| Q3 2021 | $14,646,000 | +169.0% | 1,979,130 | +427.9% | 0.24% | +134.3% |
| Q2 2021 | $5,444,000 | – | 374,912 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chescapmanager LLC | 1,134,718 | $23,160,000 | 2.47% |
| Baupost Group | 8,735,168 | $178,285,000 | 1.42% |
| Orbimed Advisors | 6,219,110 | $126,932,000 | 1.19% |
| CM Management, LLC | 50,000 | $1,021,000 | 0.76% |
| Tekla Capital Management LLC | 456,296 | $9,313,000 | 0.32% |
| Rock Springs Capital Management LP | 682,600 | $13,932,000 | 0.30% |
| Virtus ETF Advisers LLC | 32,871 | $671,000 | 0.28% |
| Cormorant Asset Management, LP | 550,000 | $11,226,000 | 0.25% |
| DAFNA Capital Management LLC | 41,165 | $840,000 | 0.20% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 484,206 | $9,883,000 | 0.18% |